UPB Competitors & Alternatives
Compare Upstream Bio, Inc. with similar stocks in the same industry
Biotechnology
UPB
Main Stock$7.63
Tradestie Score
51
Market Cap
$1.00B
Revenue Growth
0.8%
Analyst Upside
+456.1%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ATXS
Astria Therapeutics, Inc. Common Stock
|
$12.58
|
$425.52M | - | 58 | Compare |
|
ALMS
Alumis Inc. Common Stock
|
$20.08
|
$422.50M | - | 54 | Compare |
|
DRUG
Bright Minds Biosciences Inc. Common Stock
|
$74.42
|
$410.79M | - | 56 | Compare |
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$10.44
|
$386.68M | - | 53 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$6.88
|
$382.04M | - | 50 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$10.58
|
$371.64M | - | 58 | Compare |
|
CAPR
Capricor Therapeutics Inc
|
$27.64
|
$357.51M | - | 52 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$15.21
|
$354.45M | - | 54 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$27.95
|
$353.70M | - | 60 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.73
|
$350.98M | - | 54 | Compare |
More UPB Analysis
Data updated: Jun 03, 2026 | Industry: Biotechnology (SIC 2834)
222 stocks in this industry